Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Parkin (2008)The role of cancer registries in cancer control
International Journal of Clinical Oncology, 13
V. Sahasrabuddhe, M. Mwanahamuntu, S. Vermund, WK Huh, Matthieu Lyon, Jsa Stringer, G. Parham (2007)Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia
British Journal of Cancer, 96
G. Clifford, Jennifer Smith, T. Aguado, S. Franceschi (2003)Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
British Journal of Cancer, 89
G. Ho, R. Bierman, L. Beardsley, Chee-Jen Chang, R. Burk (1998)Natural history of cervicovaginal papillomavirus infection in young women
The New England Journal of Medicine, 338
C. Black, Heather Bentley, T. Davis, G. Tsongalis (2010)Use of a linear array for the detection of human papillomavirus genotypes in head and neck cancer.
Archives of pathology & laboratory medicine, 134 12
A. Nicol, Gerard Nuovo, A. Salomão-Estevez, B. Grinsztein, A. Tristão, F. Russomano, J. Silva, Maria Oliveira, Claude Pirmez (2007)Immune factors involved in the cervical immune response in the HIV/HPV co-infection
Journal of Clinical Pathology, 61
V. Bouvard, R. Baan, K. Straif, Y. Grosse, B. Secretan, F. Ghissassi, L. Benbrahim-Tallaa, N. Guha, Crystal Freeman, Laurent Galichet, V. Cogliano (2009)A review of human carcinogens--Part B: biological agents.
The Lancet. Oncology, 10 4
Margaret Piper, Sibailly Severin, S. Wiktor, E. Unger, P. Ghys, DonnaL. Miller, Ira Horowitz, A. Greenberg, W. Reeves, S. Vernon (1999)Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners.
Sexually Transmitted Infections, 75
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, David Forman (2011)Global Cancer Statistics
N. Bulkmans, J. Berkhof, L. Rozendaal, F. Kemenade, Ajp Boeke, S. Bulk, F. Voorhorst, R. Verheijen, K. Groningen, M. Boon, W. Ruitinga, M. Ballegooijen, P. Snijders, C. Meijer (2007)Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
The Lancet, 370
K. Louie, S. Sanjosé, P. Mayaud (2009)Epidemiology and prevention of human papillomavirus and cervical cancer in sub‐Saharan Africa: a comprehensive review
Tropical Medicine & International Health, 14
P. Reiter, W. Pendergraft, N. Brewer (2010)Meta-analysis of Human Papillomavirus Infection Concordance
Cancer Epidemiology, Biomarkers & Prevention, 19
A. Rodriguez, M. Schiffman, R. Herrero, A. Hildesheim, C. Bratti, M. Sherman, D. Solomon, Diego Guillén, M. Alfaro, J. Morales, M. Hutchinson, H. Katki, L. Cheung, S. Wacholder, R. Burk (2010)Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
Journal of the National Cancer Institute, 102 5
M. Arbyn, R. Sankaranarayanan, R. Muwonge, N. Keita, A. Dolo, C. Mbalawa, H. Nouhou, B. Sakande, R. Wesley, T. Somanathan, Anjali Sharma, S. Shastri, P. Basu (2008)Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India
International Journal of Cancer, 123
G. Clifford, Jennifer Smith, M. Plummer, N. Muñoz, S. Franceschi (2003)Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
British Journal of Cancer, 88
J. Levi, B. Kleter, W. Quint, M. Fink, C. Canto, R. Matsubara, I. Linhares, A. Segurado, B. Vanderborght, J. Neto, L. Doorn (2002)High Prevalence of Human Papillomavirus (HPV) Infections and High Frequency of Multiple HPV Genotypes in Human Immunodeficiency Virus-Infected Women in Brazil
Journal of Clinical Microbiology, 40
H. Vuyst, F. Lillo, N. Broutet, Jennifer Smith (2008)HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy
European Journal of Cancer Prevention, 17
Jennifer Smith, L. Lindsay, B. Hoots, J. Keys, S. Franceschi, R. Winer, G. Clifford (2007)Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
International Journal of Cancer, 121
S. Averbach, P. Gravitt, R. Nowak, D. Celentano, M. Dunbar, C. Morrison, B. Grimes, N. Padian (2010)The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe
L. Denny (2006)Cervical Cancer: The South African Perspective
International Journal of Gynecology & Obstetrics, 95
Ni Li, S. Franceschi, R. Howell-Jones, P. Snijders, G. Clifford (2011)Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
International Journal of Cancer, 128
H. Vuyst, S. Franceschi (2007)Human papillomavirus vaccines in HIV-positive men and women
Current Opinion in Oncology, 19
N. Schlecht, S. Kulaga, J. Robitaille, Silvaneide Ferreira, Monica Santos, Romulo Miyamura, E. Duarte‐Franco, T. Rohan, A. Ferenczy, L. Villa, E. Franco (2001)Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
JAMA, 286 24
A. Luque, L. Demeter, R. Reichman (1999)Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection.
The Journal of infectious diseases, 179 6
H. Strickler, R. Burk, M. Fazzari, K. Anastos, H. Minkoff, L. Massad, Charles Hall, M. Bacon, Alexandra Levine, D. Watts, M. Silverberg, X. Xue, N. Schlecht, S. Melnick, J. Palefsky (2005)Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
Journal of the National Cancer Institute, 97 8
L. Bruni, Mireia Díaz, X. Castellsagué, E. Ferrer, F. Bosch, S. Sanjosé (2010)Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.
The Journal of infectious diseases, 202 12
H. Minkoff, Linda Ahdieh, L. Massad, K. Anastos, D. Watts, S. Melnick, L. Muderspach, R. Burk, J. Palefsky (2001)The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women
Fiona Wong, J. Ching, Joseph Chow (2010)Comparison of the DiagCor GenoFlow Human Papillomavirus Array Test and Roche Linear Array HPV Genotyping Test
The Open Virology Journal, 4
G. Clifford, M. Gonçalves, S. Franceschi (2006)Human papillomavirus types among women infected with HIV: a meta-analysis
N. McKenzie, E. Kobetz, J. Hnatyszyn, L. Twiggs, J. Lucci (2010)Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types.
Gynecologic oncology, 116 3
C. Banura, S. Franceschi, L. Doorn, A. Arslan, F. Wabwire-mangen, E. Mbidde, W. Quint, E. Weiderpass (2008)Infection with human papillomavirus and HIV among young women in Kampala, Uganda.
The Journal of infectious diseases, 197 4
H. Vuyst, P. Gichangi, B. Estambale, E. Njuguna, S. Franceschi, M. Temmerman (2008)Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya
International Journal of Cancer, 122
Ramogola-Masire et al. Infectious Agents and Cancer 2010, 5(Suppl 1):A83 http://www.infectagentscancer.com/content/5/S1/A83 MEETING ABSTRACTS Open Access Type distribution of human papillomavirus in HIV- infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana 1,2* 1,2 2 2 2 Doreen Ramogola-Masire , Nicola M Zetola , Veronica de Klerk , Barati Monare , Bakgaki Ratshaa , 2 2 2 3 1 Gracious Ditlhabang , Elisabeth Chibaya , Metlha Nchunga , Mukendi K Kayembe , Kurt T Barnhart , 1 1,2 Cindy M McGrath , Harvey M Friedman th From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010 Background Results Human papillomavirus (HPV) vaccines containing This is an interim analysis of an intended sample size types 16 and 18 are remarkably effective in preventing of 100 women. We identified 30 HIV-infected women cervical cancer associated with these HPV types. No with CIN stages 2 or 3 between August 11, 2009, and information currently exists in Botswana concerning January 29, 2010. The median age was 36 (interquartile the HPV types causing precancerous or cancerous range [IQR], 33 - 38) and the median CD4 cell count 3 3 lesions. was 427 cells/mm (IQR, 360-560 cells/mm ). Of the 30 women enrolled, 28 (93%) had co-infection by mul- Methods tiple HPV types. HPV type 52 was found in the 2 (7%) The goal of this pilot project was to determine the HPV women carrying a single type. 15 (50%) had HPV types types causing precancerous cervical intraepithelial neo- 16, 18, or both. 25 (83%) women, including all the plasia (CIN) stages 2 and 3 in HIV-infected women in ones not carrying the 16 or 18 types, carried other Gaborone, Botswana. HIV-infected women referred to high-risk HPV types. Among the other high-risk types, our clinic with high-grade intraepithelial lesion (HSIL) HPV types 33, 35, and 58 were the most prevalent, on the Pap smear were enrolled in the study. Two speci- accounting for 7 (23%), 8 (27%), and 10 (33%) cases, mens were obtained on all subjects, one for histopathol- respectively. ogy and the other for HPV typing. HPV typing was performed only if the histopathology results demon- Conclusion strated CIN stage 2 or 3 disease. Histopathology results HPV 16 and 18 are the most common types in HIV- were corroborated at two sites: Lancet Laboratories infected women with CIN 2 or 3 in Gaborone, Bots- (Johannesburg, South Africa) and University of Pennsyl- wana. However, other high-risk HPV types may vania (Pennsylvania, United States). HPV typing was account for a significant number of advanced CIN performed using linear arraygenotyping(CE-IVD, lesions in this population. Roche Diagnostics). Acknowledgements This article has been published as part of Infectious Agents and Cancer th Volume 5 Supplement 1, 2010: Proceedings of the 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). The full contents of the supplement are available online at http://www.biomedcentral.com/1750-9378/5?issue=S1. *Correspondence: email@example.com Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA Full list of author information is available at the end of the article © 2010 Ramogola-Masire et al; licensee BioMed Central Ltd. Ramogola-Masire et al. Infectious Agents and Cancer 2010, 5(Suppl 1):A83 Page 2 of 2 http://www.infectagentscancer.com/content/5/S1/A83 Author details Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 2 3 Botswana-UPenn Partnership, Gaborone, Botswana. National Health Laboratory, Gaborone, Botswana. Published: 11 October 2010 doi:10.1186/1750-9378-5-S1-A83 Cite this article as: Ramogola-Masire et al.: Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana. Infectious Agents and Cancer 2010 5(Suppl 1):A83. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit
Infectious Agents and Cancer – Springer Journals
Published: Oct 11, 2010
Access the full text.
Sign up today, get DeepDyve free for 14 days.